New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease

February 5, 2026 - 21:38

A significant recall has been issued for a medication used to manage cardiovascular risk. Nearly 23,000 bottles of Icosapent Ethyl capsules are being pulled from the market due to potential product leakage.

The recall was initiated after the manufacturer identified that some capsules may have been compromised. This leakage could potentially affect the stability and potency of the medication, raising concerns that the drug may not deliver its full intended therapeutic effect. Patients relying on this prescription to lower dangerously high triglyceride levels and reduce the risk of heart attack or stroke could be impacted.

The specific lot included in this voluntary action was distributed nationwide to wholesalers and distributors. Consumers in possession of the affected capsules are advised to immediately stop using them and return the product to their pharmacy or place of purchase. Patients should contact their healthcare provider promptly to discuss alternative treatment options and should not discontinue cardiovascular therapy without medical guidance. The company is notifying its distributors and arranging for the return of all recalled lots.